
About company
Nuvo Group, Ltd. is reinventing pregnancy care for the 21st century with new technology tools and practices. The company is commercializing INVU™, a prescription-initiated, remote pregnancy monitoring platform that combines proprietary hardware for high fidelity data collection, with innovative software solutions powered by AI tools to optimize the pregnancy care experience on a global scale. INVU received 510(k) clearance from the U.S. FDA in March 2020 for maternal and fetal heart rate monitoring. Nuvo recently completed enrollment in pivotal trials to support an additional application for clearance for remote monitoring of uterine activity. Company leadership is comprised of dedicated data engineers, experienced medical and business professionals, software designers, and proud parents who embrace a collective mission to give every life a better beginning. Nuvo was founded in 2006 and is headquartered in Tel Aviv, Israel with offices in Princeton, NJ and Kyiv, Ukraine.